Tag: david_sinclair

Media Monitor: Biotech Companies Focus on Cellular Reprogramming to Reverse Aging

12 Jun 2026 5:00 a.m. · Source: MIT Technology Review

MIT Technology Review is reporting that biotech companies are increasingly focusing on cellular reprogramming to combat aging, with significant investments and human trials underway for age-related diseases like glaucoma.

Business Science & Technology Health Medical Science Economy Financial Markets Cellular Reprogramming Aging Research Biotechnology Life Biosciences Glaucoma David Sinclair Altos Labs MIT Technology Review MIT science technology
Media Monitor: Longevity Scientist David Sinclair Plans Oral Age-Reversal Drug Trials for XPrize Competition

9 Jun 2026 6:00 a.m. · Source: MIT Technology Review

MIT Technology Review reports that longevity scientist David Sinclair plans human trials for an oral 'reprogramming' drug, aiming for whole-body age reversal in an XPrize competition, despite expert caution and past criticisms.

Science & Technology Health Business Medical Science Artificial Intelligence Financial Markets David Sinclair XPrize Foundation Age Reversal Epigenetic Reprogramming Drug Trials Longevity Science Biotechnology MIT Technology Review MIT science technology